Call For Papers

  

Call for Papers and Posters
The 22nd Annual Meeting of the American Society of Pediatric Hematology/Oncology
April 22 - April 25, 2009



Important Dates
Submission:
The American Society of Pediatric Hematology/Oncology Program Committee invites the submission of abstracts for papers and posters to be presented at the 22nd Annual Meeting of the ASPHO, April 22 - April 25, 2009, in San Diego, CA.

The submittal system will remain open from September 3, 2008 to November 30, 2008. The system will close at 11:59 pm Pacific Time on November 30, 2008.

Notification:
Speakers will be notified in January, 2009 regarding selection of their proposals.

Instructions for Online Abstract Submission

This is an electronic submittal system and does not require the submission of any hard copies or disks. The system is compatible with PCs and Macintosh computers.

The goal of the ASPHO Program Committee is to solicit the very best, original, basic, clinical, and social science abstracts that relate to the field of Pediatric Hematology and Oncology. It is understood that any individual abstract may be part of an on-going project. Paper/Poster abstracts previously presented or published in whole or in part may be submitted to the ASPHO. Abstracts should be updated or modified in some way.

Authors should please note: ASPHO has always allowed previously presented work (i.e. a platform talk presented at the ASH meeting in December of the year prior to the ASPHO spring meeting) to be presented at the ASPHO meetings. Many societies/meetings do not allow such double presentation, so authors are encouraged to verify the rules for any meeting that may occur after the ASPHO. Material that has been or is expected to be published in manuscript form before the dates of the ASPHO meeting is not acceptable for presentation in either poster or platform formats.

Important Information about Submission and Issues Related to Copyright:

The primary (first) author will be asked to sign an Abstract Submission Agreement which confirms that the primary author agrees to grant ASPHO unrestricted, irrevocable permission to publish the abstract in printed materials and in a searchable PDF file.

The primary author retains the abstract's copyright, and anyone wishing to use the abstract after the ASPHO meeting will be instructed to contact the primary author for permission.

General Information:

  • Abstracts are limited to 350 words (including tables and charts). Tables and charts are allowed and will be counted toward the 350 word maxium.
  • Authors must include the following components in the body of the abstract:
      • Background
      • Objective
      • Design/Method
      • Results
      • Conclusion

    ASPHO 2009 Paper/Poster Themes and Additional Submission Information:

    It is essential that each author select a theme (topic) for the abstract being submitted. This information is used for the appropriate grouping of papers and posters at the annual meeting as well as for publication in the Pediatric Blood & Cancer Journal and on the Pediatric Blood & Cancer website.

    Please select a theme which most closely applies to your abstract:

  • Hemostasis (Coagulation & Platelets)
  • Red Cells
  • Hematology - General
  • Leukemia/Lymphoma/Histiocyte Disorders
  • Solid Tumors
  • Bone Marrow Transplant

    Please also indicate:

  • If you will be applying for the Young Investigator Award.
  • If you will be applying for the Young Investigator Travel Stipend Award.
  • If your submission is an oral presentation, poster presentation or both.
  • If this abstract was accepted at any other national meeting(s).
      • If the abstract was previously presented, indicate format: poster or platform;
      • Indicate at what meeting the abstract was presented at;
      • Indicate whether or not the abstract has been modified and why you feel a second presentation is important.
  • If you must cite a reference, please do so at the end of your abstract using the following format: author name, publication name, and year of publication, e.g., (Smith, Ped Blood & Cancer, 2002).

    All accepted abstracts will be published online and in the Pediatric Blood & Cancer Journal. Please check your submission carefully before clicking the "Submit to Program Officials" button in the submission system. ASPHO will not allow any changes to the abstract once the submittal system closes on November 30, 2008. Abstracts will be presented in the Journal and on the Journal website as they appear at the time of submission.

    "Incomplete" abstracts will not be reviewed.

    Meeting Registration Guidelines for Presenters:
    Paper and poster abstracts will be presented during specific time blocks on Thursday, April 22 - 25, 2009. Presentation times will be assigned at the time the abstract is accepted; authors cannot request a specific presentation date/time. Prior to submission of a paper or poster, at least one author must agree to attend the ASPHO meeting and to participate as the paper or poster presenter. ASPHO will not waive the registration fee for presenters. Presenters are responsible for all personal expenses (e.g., travel, hotel) for the day they present and for conference registration fees. Presenters must register for at least the day they present. Presenters are encouraged to register for the meeting and to reserve hotel accommodations as early as possible to ensure that space is available.

    Policy on Commercial Support:
    Presentations must avoid commercialism and should conform to accreditation standards for commercial support. Presentations that constitute promotion and advertising will not be accepted, including pervasive or inappropriate use of logos. No company product information may be displayed or disseminated in conjunction with the presentation. If the author(s) received any funding for this research, a clear acknowledgment of support should be included at the end of the abstract, e.g., Supported by a grant from ABC Pharmaceuticals.

    Selection Criteria:
    Paper and poster submissions will be reviewed and rated by members of the Program Committee who have expertise in the research or clinical area to which the submission belongs. Each submission will be reviewed for its scientific or clinical importance, ethical practice, and study design.

    Late Breaking Abstracts
    ASPHO does not allow late breaking abstracts. All submissions must be received by the November 30, 2008 deadline.

    Notification of Acceptance or Rejection of Submissions:
    An alphabetical list of primary (first) authors’ names will be posted on the ASPHO web site, www.aspho.org in December, 2008. This will be an author’s first opportunity to learn whether an abstract was accepted or rejected for presentation, and in what format.
    All communications will be directed to the primary (first) author. If the primary (first) and presenting author are different, communication will continue through the primary author. It is the responsibility of the primary author to communicate with the presenting author. The presenting author must be a coauthor on the abstract.

    Papers
    Primary authors on paper submissions will be notified in January of 2009 (by mail) of their abstract’s acceptance or rejection. All authors listed on the abstract will be required to complete a faculty disclosure form. Primary authors will be responsible for helping to obtain disclosure information from all co-authors. Abstracts will not be considered for the program without completion of disclosure information from all authors listed on the abstract.

    Disclosure forms will be sent to all authors once the abstracts have been selected.

    Posters
    Primary authors on poster submissions will be notified in December of 2008 (by mail) of their abstract’s acceptance or rejection.

    Start Your Submission

    Please click below to start your submission:

    PAPERS & POSTERS (350 word maximum)

    Submission Deadline 11:59pm: November 30, 2008

    Primary authors will be automatically informed of the unique ID numbers and passwords assigned to their submissions. Submissions may be viewed and modified at any time between submission and the deadline, using the assigned ID# and password.

    For help in submitting online, email Tech Support.

    Resume or View Your Submission

    If you have already submitted an abstract title -- and you wish to view, resume, edit, or withdraw that submission -- log in below using the access codes already provided to you:

    Abstract ID#       Password